Kristin N Varhaug
Overview
Explore the profile of Kristin N Varhaug including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mancuso M, Papadopoulou M, Ng Y, Ardissone A, Bellusci M, Bertini E, et al.
Eur J Neurol
. 2024 Apr;
31(7):e16275.
PMID: 38576261
Background And Purpose: Primary mitochondrial diseases (PMDs) are common inborn errors of energy metabolism, with an estimated prevalence of one in 4300. These disorders typically affect tissues with high energy...
2.
Munoz-Oreja M, Sandoval A, Bruland O, Perez-Rodriguez D, Fernandez-Pelayo U, de Arbina A, et al.
Brain
. 2024 Jan;
147(5):1899-1913.
PMID: 38242545
Aberrant cholesterol metabolism causes neurological disease and neurodegeneration, and mitochondria have been linked to perturbed cholesterol homeostasis via the study of pathological mutations in the ATAD3 gene cluster. However, whether...
3.
Boonstra N, Varhaug K
Tidsskr Nor Laegeforen
. 2023 Sep;
143(13).
PMID: 37753768
Myotonic dystrophy type 1 is one of the most common genetic neuromuscular diseases in adults. The disease not only affects the musculoskeletal system, but is multisystemic, and ocular involvement with...
4.
Varhaug K, Hikmat O, Bindoff L
Tidsskr Nor Laegeforen
. 2022 Jun;
142(10).
PMID: 35763848
Mitochondrial disease is among the most commonly occurring metabolic disorders and is relevant for many medical specialties. This clinical review article discusses one of the most common mutations causing mitochondrial...
5.
Lie I, Kacar S, Wesnes K, Brouwer I, Kvistad S, Wergeland S, et al.
J Neurol Neurosurg Psychiatry
. 2022 Jun;
PMID: 35649699
Background: The predictive value of serum neurofilament light chain (sNfL) on long-term prognosis in multiple sclerosis (MS) is still unclear. Objective: Investigate the relation between sNfL levels over a 2-year...
6.
Thomas R, Hunter A, Butterworth L, Feeney C, Graves T, Holmes S, et al.
J Inherit Metab Dis
. 2022 May;
45(4):796-803.
PMID: 35543492
Primary mitochondrial disorders encompass a wide range of clinical presentations and a spectrum of severity. They currently lack effective disease-modifying therapies and have a high mortality and morbidity rate. It...
7.
Varhaug K, Hikmat O, Nakkestad H, Vedeler C, Bindoff L
Brain Commun
. 2021 Jan;
3(1):fcaa222.
PMID: 33501425
The aim of this study was to explore the utility of the serum biomarkers neurofilament light chain, fibroblast growth factor 21 and growth and differentiation factor 15 in diagnosing primary...
8.
Bindoff L, Brown D, Gorman G, Karaa A, Keshavan N, Lamperti C, et al.
J Inherit Metab Dis
. 2020 Nov;
44(1):6-7.
PMID: 33159463
No abstract available.
9.
Varhaug K, Nido G, de Coo I, Isohanni P, Suomalainen A, Tzoulis C, et al.
Ann Clin Transl Neurol
. 2020 Jul;
7(8):1318-1326.
PMID: 32634300
Objective: The aim of this study was to evaluate if urinary sediment cells offered a robust alternative to muscle biopsy for the diagnosis of single mtDNA deletions. Methods: Eleven adult...
10.
Rosjo E, Lindstrom J, Holmoy T, Myhr K, Varhaug K, Torkildsen O
Front Neurol
. 2020 May;
11:329.
PMID: 32425877
High serum levels of 25-hydroxyvitamin D (25(OH)D) have been found among patients with a favorable disease course in relapsing-remitting MS (RRMS), indicating that this may limit clinical deterioration. Clinical deterioration...